$ADMA Stock Notification: ADMA Biologics Stock Plummets 29% After Channel Stuffing Allegations - Securities Fraud Class Action Filed on Behalf of Investors

Bleichmar Fonti & Auld LLP announced a class action lawsuit against ADMA Biologics on behalf of investors, alleging securities fraud related to a channel stuffing scheme and undisclosed related party transactions. The litigation follows significant stock declines in March 2026, reportedly triggered by a critical research report from Culper Research and a subsequent downgrade from Cantor Fitzgerald.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.